431 related articles for article (PubMed ID: 11910259)
1. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
Bergeron R; Ravindran AV; Chaput Y; Goldner E; Swinson R; van Ameringen MA; Austin C; Hadrava V
J Clin Psychopharmacol; 2002 Apr; 22(2):148-54. PubMed ID: 11910259
[TBL] [Abstract][Full Text] [Related]
2. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
Ninan PT; Koran LM; Kiev A; Davidson JR; Rasmussen SA; Zajecka JM; Robinson DG; Crits-Christoph P; Mandel FS; Austin C
J Clin Psychiatry; 2006 Jan; 67(1):15-22. PubMed ID: 16426083
[TBL] [Abstract][Full Text] [Related]
3. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
March JS; Biederman J; Wolkow R; Safferman A; Mardekian J; Cook EH; Cutler NR; Dominguez R; Ferguson J; Muller B; Riesenberg R; Rosenthal M; Sallee FR; Wagner KD; Steiner H
JAMA; 1998 Nov; 280(20):1752-6. PubMed ID: 9842950
[TBL] [Abstract][Full Text] [Related]
4. Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.
Kronig MH; Apter J; Asnis G; Bystritsky A; Curtis G; Ferguson J; Landbloom R; Munjack D; Riesenberg R; Robinson D; Roy-Byrne P; Phillips K; Du Pont IJ
J Clin Psychopharmacol; 1999 Apr; 19(2):172-6. PubMed ID: 10211919
[TBL] [Abstract][Full Text] [Related]
5. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.
Cook EH; Wagner KD; March JS; Biederman J; Landau P; Wolkow R; Messig M
J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1175-81. PubMed ID: 11589530
[TBL] [Abstract][Full Text] [Related]
6. Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.
Ghobadian A; Mokhtari S; Shariati B; Kamalzadeh L; Shati M; Eftekhar Ardebili M; Yarahmadi M; Shalbafan M
BMC Pharmacol Toxicol; 2022 Sep; 23(1):73. PubMed ID: 36167636
[TBL] [Abstract][Full Text] [Related]
7. A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder.
Bisserbe J; Lane R; Flament M;
Eur Psychiatry; 1997; 12(2):82-93. PubMed ID: 19698511
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.
Koran LM; Ringold AL; Elliott MA
J Clin Psychiatry; 2000 Jul; 61(7):514-7. PubMed ID: 10937610
[TBL] [Abstract][Full Text] [Related]
9. Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder.
Wagner KD; Cook EH; Chung H; Messig M
J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S53-60. PubMed ID: 12880500
[TBL] [Abstract][Full Text] [Related]
10. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.
Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M
BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder: A Double-Blind Controlled Clinical Trial.
Mowla A; Boostani S; Dastgheib SA
J Clin Psychopharmacol; 2016 Dec; 36(6):720-723. PubMed ID: 27811556
[TBL] [Abstract][Full Text] [Related]
12. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
Chouinard G; Goodman W; Greist J; Jenike M; Rasmussen S; White K; Hackett E; Gaffney M; Bick PA
Psychopharmacol Bull; 1990; 26(3):279-84. PubMed ID: 2274626
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder.
Zitterl W; Meszaros K; Hornik K; Twaroch T; Dossenbach M; Zitterl-Eglseer K; Zapotoczky HG
Wien Klin Wochenschr; 1999 Jun; 111(11):439-42. PubMed ID: 10420495
[TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
Sechter D; Troy S; Paternetti S; Boyer P
Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
[TBL] [Abstract][Full Text] [Related]
15. Insight and treatment outcome in obsessive-compulsive disorder.
Eisen JL; Rasmussen SA; Phillips KA; Price LH; Davidson J; Lydiard RB; Ninan P; Piggott T
Compr Psychiatry; 2001; 42(6):494-7. PubMed ID: 11704942
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.
Liebowitz MR; Turner SM; Piacentini J; Beidel DC; Clarvit SR; Davies SO; Graae F; Jaffer M; Lin SH; Sallee FR; Schmidt AB; Simpson HB
J Am Acad Child Adolesc Psychiatry; 2002 Dec; 41(12):1431-8. PubMed ID: 12447029
[TBL] [Abstract][Full Text] [Related]
17. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
Landeros-Weisenberger A; Bloch MH; Kelmendi B; Wegner R; Nudel J; Dombrowski P; Pittenger C; Krystal JH; Goodman WK; Leckman JF; Coric V
J Affect Disord; 2010 Feb; 121(1-2):175-9. PubMed ID: 19577308
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
Besiroglu L; Çetinkaya N; Selvi Y; Atli A
Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial.
Bystritsky A; Ackerman DL; Rosen RM; Vapnik T; Gorbis E; Maidment KM; Saxena S
J Clin Psychiatry; 2004 Apr; 65(4):565-8. PubMed ID: 15119922
[TBL] [Abstract][Full Text] [Related]
20. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
Rasmussen S; Hackett E; DuBoff E; Greist J; Halaris A; Koran LM; Liebowitz M; Lydiard RB; McElroy S; Mendels J; O'Connor K
Int Clin Psychopharmacol; 1997 Nov; 12(6):309-16. PubMed ID: 9547132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
